Actively Recruiting

Age: 18Years +
FEMALE
NCT06946563

Fetoscopic Neural Tube Defect Repair

Led by Oregon Health and Science University · Updated on 2025-04-27

25

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, post-operative, delivery, and neonatal outcomes will be collected.

CONDITIONS

Official Title

Fetoscopic Neural Tube Defect Repair

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Maternal age 18 years or older
  • Able to consent for participation
  • Decision to have fetoscopic repair after counseling
  • Open spina bifida with upper boundary between T1 and S1
  • Gestational age between 24 0/7 and 26 6/7 weeks at surgery
  • Normal karyotype or chromosomal microarray; inclusion decisions for uncertain variants by investigators
  • No major cardiac anomalies by fetal echocardiogram
  • Adequate social support during pregnancy
  • Willingness for child follow-up evaluations after birth
Not Eligible

You will not qualify if you...

  • Multiple gestation pregnancy
  • Major fetal anomalies unrelated to neural tube defect
  • Fetal kyphosis of 30 degrees or more
  • Previous spontaneous singleton preterm birth before 37 weeks
  • Presence of cervical cerclage or history of cervical insufficiency
  • Cervical length under 20 mm by ultrasound
  • Placenta previa or placental abruption
  • Large uterine fibroids, uterine anomalies, or fetal membrane separation increasing surgical risk
  • Maternal obesity with BMI over 45 or challenging body habitus
  • Alloimmunization in pregnancy including Kell sensitization or neonatal alloimmune thrombocytopenia history
  • Maternal HIV or Hepatitis B positive; negative test required if status unknown
  • Known Hepatitis C positive status
  • Maternal medical conditions contraindicating surgery or anesthesia
  • Medical co-morbidities increasing preterm delivery risk
  • Inability to comply with travel and follow-up
  • Psychosocial criteria not met for medical care and follow-up
  • Participation in another interventional study affecting maternal or fetal outcomes
  • Known allergy to collagen or chondroitin products

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

Loading map...

Research Team

W

Women's Health Research Unit Department of Ob/Gyn

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here